Study of Covalent Menin Inhibitor BMF-219 in Adult Patients With KRAS Driven Non-Small Cell Lung Cancer, Pancreatic Cancer, and Colorectal Cancer

Clinical trial NCT05631574 · TERMINATED

Trial details

NCT number: NCT05631574
Sponsor: Biomea Fusion Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer Pancreatic Cancer Colorectal Cancer NSCLC PDAC CRC Relapsed Cancer Refractory Cancer Stage III Pancreatic Cancer Stage IV Pancreatic Cancer Stage III Non-small Cell Lung Cancer Stage IV Non-small Cell Lung Cancer

Start date: 2023-01-12
Primary completion: 2025-01-15
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.